Verdence Capital Advisors’s Exact Sciences EXAS Stock Holding History

Verdence Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,002	Closed	-$1.49M	–	551
2022 Q4	$1.49M	Buy	30,002 +2	+0%	+$82	0.18%	131
2022 Q3	$975K	Sell	30,000 -4	-0%	-$165	0.13%	169
2022 Q2	$1.18M	Sell	30,004 -3	-0%	-$160	0.15%	154
2022 Q1	$2.1M	Buy	+30,007	New	+$2.19M	0.24%	107
2018 Q3	–	Sell	-4,100	Closed	-$245K	–	274
2018 Q2	$245K	Buy	+4,100	New	+$221K	0.06%	238
2018 Q1	–	Sell	-4,100	Closed	-$215K	–	305
2017 Q4	$215K	Buy	+4,100	New	+$219K	0.05%	259

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Verdence Capital Advisors's EXAS Position: Q1 2023 in Review

Verdence Capital Advisors sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 30,002 shares — an estimated $1.49M sold.

Verdence Capital Advisors first reported a position in EXAS in Q4 2017 and held it in 6 quarters. The position peaked at $2.1M in Q1 2022. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

Verdence Capital Advisors reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
Verdence Capital Advisors sold 30,002 Exact Sciences shares in Q1 2023, an estimated $1.49M.
Verdence Capital Advisors first reported a position in Exact Sciences in Q4 2017 and held it in 6 quarters.
Verdence Capital Advisors's Exact Sciences position peaked at $2.1M in Q1 2022.
583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Verdence Capital Advisors's 13F filing for Q1 2023, filed 24 Apr 2023.